Buscar
Mostrando ítems 11-20 de 459
Premenopausal Women May Not Be Protected Against Early Vascular Disease In The Presence Of Diabetes
(American Heart Association Customer ServiceAmerican Heart Association Customer Service, 2013)
Coronary heart disease (CHD) is the leading cause of death among women. Currently, global risk assessment derived by a Framingham risk equation is used to identify women at increased risk, but still we do not detect them ...
Metabolic Syndrome and Mammographic Density in Premenopausal Chilean Women
(2017)
Background: Metabolic syndrome (MetS) has been previously associated with an increased risk of breast cancer in postmenopausal women. Mammographic density (MD) is a marker of breast cancer risk. There is little evidence ...
Effects of raloxifene on normal breast tissue from premenopausal women
(Springer, 2006-01-01)
The objective of this study was to evaluate the effects of raloxifene oil normal breast tissue. A randomized, doubleblind study was carried out in 30 ovulatory, premenopausal women of 18-40 years of age, who had been ...
Metabolic Syndrome and Mammographic Density in Premenopausal Chilean Women
(Routledge, 2017)
Background: Metabolic syndrome (MetS) has been previously associated with an increased risk of
breast cancer in postmenopausal women. Mammographic density (MD) is a marker of breast cancer
risk. There is little evidence ...
Menopause status is associated with circadian- and sleep-related alterations
(Lippincott Williams and Wilkins, 2016)
Risk of vascular disease in premenopausal women with diabetes mellitus
(Elsevier Science, 2014-12)
Purpose: The aims of this study were (1) to estimate the prevalence of cardiovascular disease risk factors among premenopausal and menopausal Argentinean women with and without type 2 diabetes mellitus and (2) to assess ...
Effect of a half dose of tamoxifen on proliferative activity in normal breast tissue
(Elsevier B.V., 1999-10-01)
Objectives: To investigate the proliferative activity of the mammary gland epithelium and plasma levels of progesterone, estradiol, prolactin, luteinizing hormone (LH), follicle-stimulating hormone (FSH) and sex hormone-binding ...
Sequential treatment for idiopathic osteoporosis in premenopausal women: A case report
(Wiley, 2020)
Idiopathic osteoporosis (IOP) affects young, otherwise healthy individuals with intact gonadal function and no secondary cause for bone loss or fragility. IOP may be associated with major osteoporotic fractures such as ...
Action of aromatase inhibitor for treatment of uterine leiomyoma in perimenopausal patients
(ELSEVIER SCIENCE INC, 2009)
Objective: To assess the effect of the aromatase inhibitor on patients with leiomyoma in the reproductive stage regarding reduction of uterine volume and control of symptoms. Design: Clinical study. Setting: Academic ...